Invex Therapeutics Hits Recruitment Roadblocks in IIH Study
Source: pixabay.com

Invex Therapeutics Hits Recruitment Roadblocks in IIH Study

When biopharmaceutical company Invex Therapeutics (“Invex”) first decided to launch a clinical trial to evaluate Presendin (sustained-release exenatide) for idiopathic intracranial hypertension (IIH), the company felt excited. Presendin is a…

Continue Reading Invex Therapeutics Hits Recruitment Roadblocks in IIH Study
Woman Remains Blessed Amidst Idiopathic Intracranial Hypertension Diagnosis
Source: Pixabay

Woman Remains Blessed Amidst Idiopathic Intracranial Hypertension Diagnosis

While April Archote faces the physical pain and financial hardships of living with a rare brain disease, she continues to be positive and count her blessings, CCHeadliner reported. In 2013, April was…

Continue Reading Woman Remains Blessed Amidst Idiopathic Intracranial Hypertension Diagnosis